Recombinant Human CALCB Protein ，GST

CALCB (Calcitonin Gene-Related Peptide Beta) is a neuropeptide that plays a significant role in various physiological processes, including pain modulation, neurogenic inflammation, and vascular regulation. Its importance in the central and peripheral nervous systems has prompted extensive research into its structure and function, particularly in the context of diseases such as migraine, where elevated levels of CALCB are observed. Researchers are particularly interested in the recombinant production of CALCB to facilitate detailed studies on its biological activity and therapeutic potential. Recombinant proteins allow for the generation of large quantities of pure CALCB, which is essential for characterizing its interactions with specific receptors and elucidating its signaling pathways. This has implications not only for understanding pain mechanisms but also for the development of novel therapeutic strategies targeting CALCB-related pathways. Moreover, the investigation of CALCB’s role in pathological conditions could lead to breakthroughs in treating conditions such as cardiovascular diseases, where its vasodilatory effects and involvement in homeostasis are crucial. Consequently, the recombinant expression of CALCB serves as a vital tool in both basic research and clinical applications, ultimately advancing our understanding of this important neuropeptide and its potential as a therapeutic target.